BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 20846568)

  • 1. Survey on the Management of Dysplastic Nevus by Dermatologists in the Center-Spain section of the Spanish Academy of Dermatology and Venereology (AEDV).
    Baeza-Hernández G; Rubio-Aguilera RF; Martínez-Morán C; Álvarez-Garrido H; Garrido-Ríos AA; Borbujo J
    Actas Dermosifiliogr; 2023; 114(10):850-857. PubMed ID: 37482291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in nomenclature usage and preference among dermatopathologists for "dysplastic" nevi: A national survey.
    Green AR; Moshiri A; Hippe DS; Raymundo C; Piepkorn M; Shinohara MM
    J Cutan Pathol; 2023 Jun; 50(6):530-535. PubMed ID: 36239041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodynamic excisional skin tension lines for surgical excisions: untangling the science.
    Paul SP
    Ann R Coll Surg Engl; 2018 Apr; 100(4):330-337. PubMed ID: 29543064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging infectious diseases of the skin: a review of clinical and histologic findings.
    McMahon DE; Schuetz AN; Kovarik CL
    Hum Pathol; 2023 Oct; 140():196-213. PubMed ID: 37454994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of surgical margins in melanocytic lesions: a survey among 152 dermatopathologists.
    Sellheyer K; Bergfeld WF; Stewart E; Roberson G; Hammel J
    J Cutan Pathol; 2005 Apr; 32(4):293-9. PubMed ID: 15769279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the depth of excision of melanoma: A survey of US physicians.
    DeFazio JL; Marghoob AA; Pan Y; Dusza SW; Khokhar A; Halpern A
    Arch Dermatol; 2010 Sep; 146(9):995-9. PubMed ID: 20644028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in the diagnosis, treatment, and management of melanoma in situ: a survey of US dermatologists.
    Charles CA; Yee VS; Dusza SW; Marghoob AA; Oliveria SA; Kopf A; Rigel D; Halpern AC
    Arch Dermatol; 2005 Jun; 141(6):723-9. PubMed ID: 15967918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nongrading histologic approach to Clark (dysplastic) nevi: A potential to decrease the excision rate.
    Lozeau DF; Farber MJ; Lee JB
    J Am Acad Dermatol; 2016 Jan; 74(1):68-74. PubMed ID: 26549250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.
    Reddy KK; Farber MJ; Bhawan J; Geronemus RG; Rogers GS
    JAMA Dermatol; 2013 Aug; 149(8):928-34. PubMed ID: 23760581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists.
    Kolman O; Hoang MP; Piris A; Mihm MC; Duncan LM
    J Am Acad Dermatol; 2010 Oct; 63(4):661-7. PubMed ID: 20846568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview.
    Kanzler MH; Mraz-Gernhard S
    J Am Acad Dermatol; 2001 Aug; 45(2):260-76. PubMed ID: 11464189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What sentinel node biopsy in patients with melanoma (or patients whose doctors worry that they could have melanoma) might and might not do.
    LeBoit PE
    Clin Dermatol; 2009; 27(6):588-93. PubMed ID: 19880045
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.